Augmented and Virtual Reality in Healthcare Market Size, Share, and Trends 2024 to 2033

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Augmented and Virtual Reality in Healthcare Market 

5.1. COVID-19 Landscape: Augmented and Virtual Reality in Healthcare Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Augmented and Virtual Reality in Healthcare Market, By Component

8.1. Augmented and Virtual Reality in Healthcare Market, by Component, 2024-2033

8.1.1. Hardware

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. Software

8.1.2.1. Market Revenue and Forecast (2021-2033)

8.1.3. Services

8.1.3.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Augmented and Virtual Reality in Healthcare Market, By Technology

9.1. Augmented and Virtual Reality in Healthcare Market, by Technology e, 2024-2033

9.1.1. Augmented Reality

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Augmented Reality

9.1.2.1. Market Revenue and Forecast (2021-2033)

Chapter 10. Global Augmented and Virtual Reality in Healthcare Market, By End User 

10.1. Augmented and Virtual Reality in Healthcare Market, by End User, 2024-2033

10.1.1. Hospitals, Clinics, and Surgical Centers

10.1.1.1. Market Revenue and Forecast (2021-2033)

10.1.2. Research Organizations and Pharma Companies

10.1.2.1. Market Revenue and Forecast (2021-2033)

10.1.3. Research and Diagnostics Laboratories

10.1.3.1. Market Revenue and Forecast (2021-2033)

10.1.4. Government and Defense Institutions

10.1.4.1. Market Revenue and Forecast (2021-2033)

10.1.5. Others

10.1.5.1. Market Revenue and Forecast (2021-2033)

Chapter 11. Global Augmented and Virtual Reality in Healthcare Market, By Application 

11.1. Augmented and Virtual Reality in Healthcare Market, by Application, 2024-2033

11.1.1. Surgery

11.1.1.1. Market Revenue and Forecast (2021-2033)

11.1.2. Therapy

11.1.2.1. Market Revenue and Forecast (2021-2033)

11.1.3. Education and training

11.1.3.1. Market Revenue and Forecast (2021-2033)

11.1.4. Rehabilitation

11.1.4.1. Market Revenue and Forecast (2021-2033)

11.1.5. Pain management

11.1.5.1. Market Revenue and Forecast (2021-2033)

11.1.5. Others

11.1.5.1. Market Revenue and Forecast (2021-2033)

Chapter 12. Global Augmented and Virtual Reality in Healthcare Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Component (2021-2033)

12.1.2. Market Revenue and Forecast, by Technology (2021-2033)

12.1.3. Market Revenue and Forecast, by End User (2021-2033)

12.1.4. Market Revenue and Forecast, by Application (2021-2033)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Component (2021-2033)

12.1.5.2. Market Revenue and Forecast, by Technology (2021-2033)

12.1.5.3. Market Revenue and Forecast, by End User (2021-2033)

12.1.5.4. Market Revenue and Forecast, by Application (2021-2033)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Component (2021-2033)

12.1.6.2. Market Revenue and Forecast, by Technology (2021-2033)

12.1.6.3. Market Revenue and Forecast, by End User (2021-2033)

12.1.6.4. Market Revenue and Forecast, by Application (2021-2033)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Component (2021-2033)

12.2.2. Market Revenue and Forecast, by Technology (2021-2033)

12.2.3. Market Revenue and Forecast, by End User (2021-2033)

12.2.4. Market Revenue and Forecast, by Application (2021-2033)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Component (2021-2033)

12.2.5.2. Market Revenue and Forecast, by Technology (2021-2033)

12.2.5.3. Market Revenue and Forecast, by End User (2021-2033)

12.2.5.4. Market Revenue and Forecast, by Application (2021-2033)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Component (2021-2033)

12.2.6.2. Market Revenue and Forecast, by Technology (2021-2033)

12.2.6.3. Market Revenue and Forecast, by End User (2021-2033)

12.2.6.4. Market Revenue and Forecast, by Application (2021-2033)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Component (2021-2033)

12.2.7.2. Market Revenue and Forecast, by Technology (2021-2033)

12.2.7.3. Market Revenue and Forecast, by End User (2021-2033)

12.2.7.4. Market Revenue and Forecast, by Application (2021-2033)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Component (2021-2033)

12.2.8.2. Market Revenue and Forecast, by Technology (2021-2033)

12.2.8.3. Market Revenue and Forecast, by End User (2021-2033)

12.2.8.4. Market Revenue and Forecast, by Application (2021-2033)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Component (2021-2033)

12.3.2. Market Revenue and Forecast, by Technology (2021-2033)

12.3.3. Market Revenue and Forecast, by End User (2021-2033)

12.3.4. Market Revenue and Forecast, by Application (2021-2033)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Component (2021-2033)

12.3.5.2. Market Revenue and Forecast, by Technology (2021-2033)

12.3.5.3. Market Revenue and Forecast, by End User (2021-2033)

12.3.5.4. Market Revenue and Forecast, by Application (2021-2033)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Component (2021-2033)

12.3.6.2. Market Revenue and Forecast, by Technology (2021-2033)

12.3.6.3. Market Revenue and Forecast, by End User (2021-2033)

12.3.6.4. Market Revenue and Forecast, by Application (2021-2033)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Component (2021-2033)

12.3.7.2. Market Revenue and Forecast, by Technology (2021-2033)

12.3.7.3. Market Revenue and Forecast, by End User (2021-2033)

12.3.7.4. Market Revenue and Forecast, by Application (2021-2033)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Component (2021-2033)

12.3.8.2. Market Revenue and Forecast, by Technology (2021-2033)

12.3.8.3. Market Revenue and Forecast, by End User (2021-2033)

12.3.8.4. Market Revenue and Forecast, by Application (2021-2033)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Component (2021-2033)

12.4.2. Market Revenue and Forecast, by Technology (2021-2033)

12.4.3. Market Revenue and Forecast, by End User (2021-2033)

12.4.4. Market Revenue and Forecast, by Application (2021-2033)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Component (2021-2033)

12.4.5.2. Market Revenue and Forecast, by Technology (2021-2033)

12.4.5.3. Market Revenue and Forecast, by End User (2021-2033)

12.4.5.4. Market Revenue and Forecast, by Application (2021-2033)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Component (2021-2033)

12.4.6.2. Market Revenue and Forecast, by Technology (2021-2033)

12.4.6.3. Market Revenue and Forecast, by End User (2021-2033)

12.4.6.4. Market Revenue and Forecast, by Application (2021-2033)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Component (2021-2033)

12.4.7.2. Market Revenue and Forecast, by Technology (2021-2033)

12.4.7.3. Market Revenue and Forecast, by End User (2021-2033)

12.4.7.4. Market Revenue and Forecast, by Application (2021-2033)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Component (2021-2033)

12.4.8.2. Market Revenue and Forecast, by Technology (2021-2033)

12.4.8.3. Market Revenue and Forecast, by End User (2021-2033)

12.4.8.4. Market Revenue and Forecast, by Application (2021-2033)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Component (2021-2033)

12.5.2. Market Revenue and Forecast, by Technology (2021-2033)

12.5.3. Market Revenue and Forecast, by End User (2021-2033)

12.5.4. Market Revenue and Forecast, by Application (2021-2033)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Component (2021-2033)

12.5.5.2. Market Revenue and Forecast, by Technology (2021-2033)

12.5.5.3. Market Revenue and Forecast, by End User (2021-2033)

12.5.5.4. Market Revenue and Forecast, by Application (2021-2033)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Component (2021-2033)

12.5.6.2. Market Revenue and Forecast, by Technology (2021-2033)

12.5.6.3. Market Revenue and Forecast, by End User (2021-2033)

12.5.6.4. Market Revenue and Forecast, by Application (2021-2033)

Chapter 13. Company Profiles

13.1. Eon Reality, Inc

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Layar

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Bioflight VR

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. WorldViz

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. TheraSim Inc

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. CAE

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. GE Healthcare

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Koninklijke Philips N.V.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Intuitive Surgical

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Siemens Ltd

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms